Modern Medicine (Sep 2022)

The Impact of Next Generation Sequencing in Diagnosis and Management of Rare Diseases: Bloom Syndrome

  • Ina-Ofelia FOCSA,
  • Andreea TUTULAN-CUNITA,
  • Anca PAVEL,
  • Diana PREPELITA,
  • Diana BRATU,
  • Laurentiu Camil BOHILTEA,
  • Danae STAMBOULI

DOI
https://doi.org/10.31689/rmm.2022.29.3.187
Journal volume & issue
Vol. 29, no. 3
pp. 187 – 192

Abstract

Read online

Bloom syndrome is an exceptionally rare autosomal recessive disorder characterized by a considerable genomic instability due to the defective DNA damage repair machine. It is caused by biallelic pathogenic variants in the gene encoding for one of the five human RecQ helicases, RECQL3/BLM. The disorder manifests clinically as growth deficiency, skin anomalies, immunodeficiencies, insulin resistance, and a high predisposition to cancers. Less than 300 patients have been reported so far. In this paper, we report on the first Romanian patient of bi-ethnic origin, molecularly diagnosed with Bloom syndrome. As the most severe complications of the disorder are the malignancies, developing even in childhood, an early diagnosis is essential for further surveillance and therapeutic approach of Bloom patients.

Keywords